Mubadala expands UAE healthcare logistics reach

Abu Dhabi’s Mubadala Investment Company has acquired an 80 percent stake in Global Medical Supply Chain and Al Ittihad Drug Store from GlobalOne Healthcare Holding, the healthcare division of UAE-based Yas Holding.

GlobalOne Healthcare Holding will retain a 20 percent stake in both companies.

The acquisition expands Mubadala’s footprint in healthcare logistics and pharmaceutical distribution. No financial details were given.

Global Medical Supply Chain provides end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing and maintenance. It serves more than 200 medical facilities across the country.

Al Ittihad Drug Store distributes pharmaceutical and consumer healthcare products. It distributes more than 1,000 products from over 40 suppliers, covering multiple therapeutic categories such as anti-infectives, asthma, diabetes and oncology.

• Mubadala-led group buys stake in US company Zelis
• M42 buys European dialysis group Diaverum
• Mubadala-backed US startup working on AI cancer care

Ismail Ali Abdulla, executive director of UAE clusters at Mubadala’s UAE investments platform, said the expanding pharmaceutical market drives an increasing demand for specialised and efficient drug logistics solutions.

Low Ping, group CEO at Yas Holding, said the transaction strengthens Mubadala’s commitment to the UAE’s healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification.

In March Mubadala signed a definitive agreement to acquire Kelix Bio, a specialty pharmaceutical business in the UAE that focuses on delivering complex generics across emerging markets, from GHH.

According to research from investment banking advisory firm Alpen Capital, healthcare spending in the GCC region is set to reach $135.5 billion in 2027, implying annual growth of 5 percent from $104 billion last year.